Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Coney

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
International Medical Case Reports Journal|June 20, 2019
Fluocinolone acetonide 0.19 mg intravitreal implant improves foveal thickness and reduces treatment burden for up to 1 year in eyes with persistent diabetic macular edemaJoseph M Coney
The American Journal of Managed Care|November 21, 2019
Addressing unmet needs in diabetic retinopathyJoseph M Coney
Journal of the National Medical Association|February 2, 2022
Racial disparities in the screening and treatment of diabetic retinopathyJoseph M Coney, Adrienne W Scott
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|April 20, 2004
Binocular indirect panretinal laser photocoagulation for the treatment of proliferative diabetic retinopathyGokhan Gurelik, Joseph M Coney, Z Nicholas Zakov
Journal of Vitreoretinal Diseases|November 12, 2025
Real-World Clinical Outcomes After Sustained Delivery of the 0.19 mg Fluocinolone Acetonide Implant for Treatment of Diabetic Macular EdemaSarah Godel, Damla Oncel, Richard Donkor, et al.
Expert Opinion on Pharmacotherapy|May 10, 2011
Pegaptanib octasodium for the treatment of diabetic macular edemaJerome P Schartman, Joseph M Coney, Joan H Hornik, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|November 4, 2023
Early surgical displacement of submacular hemorrhage without tissue plasminogen activator use: one-year outcomesMarwan Abdulaal, Richard Donkor, Jacobi Robertson, et al.
Ophthalmology and Therapy|June 13, 2023
Real-World Frequency and Management of Ocular Adverse Events in Eyes with Neovascular Age-Related Macular Degeneration Treated with BrolucizumabRyan Zubricky, Jasmyne McCoy, Richard Donkor, et al.
Retina (Philadelphia, Pa.)|June 4, 2005
Congenital retinal macrovesselRama D Jager, Nigel H Timothy, Joseph M Coney, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 13, 2026
Real-World Anatomical Outcomes of Suprachoroidal Triamcinolone Acetonide Injections in a Large Retinal Practice over a 4-Year PeriodChase W Miller, Casey A Scroggins, Shannon L Wuller, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Medical Case Reports Journal|June 20, 2019
Fluocinolone acetonide 0.19 mg intravitreal implant improves foveal thickness and reduces treatment burden for up to 1 year in eyes with persistent diabetic macular edemaJoseph M Coney
The American Journal of Managed Care|November 21, 2019
Addressing unmet needs in diabetic retinopathyJoseph M Coney
Journal of the National Medical Association|February 2, 2022
Racial disparities in the screening and treatment of diabetic retinopathyJoseph M Coney, Adrienne W Scott
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|April 20, 2004
Binocular indirect panretinal laser photocoagulation for the treatment of proliferative diabetic retinopathyGokhan Gurelik, Joseph M Coney, Z Nicholas Zakov
Journal of Vitreoretinal Diseases|November 12, 2025
Real-World Clinical Outcomes After Sustained Delivery of the 0.19 mg Fluocinolone Acetonide Implant for Treatment of Diabetic Macular EdemaSarah Godel, Damla Oncel, Richard Donkor, et al.
Expert Opinion on Pharmacotherapy|May 10, 2011
Pegaptanib octasodium for the treatment of diabetic macular edemaJerome P Schartman, Joseph M Coney, Joan H Hornik, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|November 4, 2023
Early surgical displacement of submacular hemorrhage without tissue plasminogen activator use: one-year outcomesMarwan Abdulaal, Richard Donkor, Jacobi Robertson, et al.
Ophthalmology and Therapy|June 13, 2023
Real-World Frequency and Management of Ocular Adverse Events in Eyes with Neovascular Age-Related Macular Degeneration Treated with BrolucizumabRyan Zubricky, Jasmyne McCoy, Richard Donkor, et al.
Retina (Philadelphia, Pa.)|June 4, 2005
Congenital retinal macrovesselRama D Jager, Nigel H Timothy, Joseph M Coney, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 13, 2026
Real-World Anatomical Outcomes of Suprachoroidal Triamcinolone Acetonide Injections in a Large Retinal Practice over a 4-Year PeriodChase W Miller, Casey A Scroggins, Shannon L Wuller, et al.
Pageof 2